Objective To explore the knowledge and attitudes of psychiatrists about psychedelics
therapies. Method Access to a cross-sectional survey was distributed to psychiatrists through …

Objective To assess Australian psychiatrists' and psychiatry trainees' knowledge of and
attitudes towards psychedelics as treatment for psychiatric disorders. Method Australian …

Finally, while not considered a classical psychedelic, 3, 4-
methylenedioxymethamphetamine (MDMA) shows promise for the treatment of …

Author's reply: MDMA research is a fascinating branch of research medicine that is now
really taking off. Dr Pathania refers to the recent work of Mithoefer and colleagues, whose …

In raising the question of the barriers to Australia initiating a psychedelic research
programme, Strauss et al.(2016) make an observation that should not be ignored–that …

Introduction: Psychedelic-assisted psychotherapy is a promising approach in psychiatry;
evidence is growing and it may not be long before mainstream services are expected to offer …

With the extensive public, commercial and scientific interest from what has been widely
termed the psychedelic renaissance, it is important that the scientific practices and results …

Recent clinical studies illustrate that psychedelics such as LSD and psilocybin may
represent much-needed new treatment options for mood disorders and alcohol and other …

Introduction Despite the rapid advance of psychedelic science and possible translation of
psychedelic therapy into the psychiatric clinic, very little is known about mental health …

Introduction This study explored the current knowledge, attitudes, and clinical practices
regarding psychedelics among mental health professionals in California, where state …